1. The authors are members of the Committee on Genetic Information and the Workplace of the National Action Plan on Breast Cancer (NAPBC) and the National Institutes of Health-Department of Energy Working Group on Ethical, Legal and Social Implications of Human Genome Research (the ELSI Working Group).
2. K. Rothenberg is director of the Law and Health Care Program, University of Maryland School of Law, and chair of the Committee on Genetic Information and the Workplace and is a member of the NAPBC.
3. B. Fuller is with the NAPBC.
4. M. Rothstein is at the Health Law and Policy Institute, University of Houston Law Center, and a member of the NAPBC.
5. T. Duster is at the Institute for the Study of Social Change, University of California, Berkeley, and is chair of the ELSI Working Group.
6. M. J. Ellis Kahn is with the Virginia Breast Cancer Foundation and is co-chair of the NAPBC Hereditary Susceptibility Working Group.
7. R. Cunningham is with the African American Breast Cancer Alliance of Minnesota and is a member of the NAPBC.
8. B. Fine is at Northwestern University Medical School and is a member of the ELSI Working Group.
9. K. Hudson is at the National Human Genome Research Institute, National Institutes of Health.
10. M.-C. King is with the Division of Medical Genetics, University of Washington, and is a member of the NAPBC.
11. P. Murphy is with OncorMed, Gaithersburg, MD, and is a member of the NAPBC.
12. G. Swergold is at the Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, and is a member of the NAPBC.
13. F. Collins is at the National Human Genome Research Institute, National Institutes of Health, and is co-chair of the NAPBC Hereditary Susceptibility Working Group.